phosphorodithioic acid has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Yousif, AO; Cardin, D; Ciavarri, J; Conlon, J; Cullis, C; England, D; Gershman, R; Gigstad, K; Gipson, K; Gould, A; Greenspan, P; Griffin, R; Gulavita, N; Harrison, S; Hata, A; Hu, Y; Hu, Z; Huang, J; Huang, SC; Janowick, D; Jones, M; Kolev, V; Langston, SP; Lee, HM; Li, G; Lok, D; Ma, L; Mai, D; Malley, J; Matsuda, A; Mizutani, H; Mizutani, M; Molchanova, N; Nunes, E; Pusalkar, S; Renou, C; Rowland, S; Sato, Y; Shaw, M; Shen, L; Shi, Z; Skene, R; Soucy, F; Stroud, S; Vyskocil, S; Xu, H; Xu, T; Zhang, J | 1 |
| Lu, Y | 1 |
1 review(s) available for phosphorodithioic acid and Benign Neoplasms
| Article | Year |
|---|---|
Recent advances in the stereocontrolled synthesis of antisense phosphorothioates.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Design; Genetic Therapy; Humans; Models, Chemical; Neoplasms; Oligonucleotides, Antisense; Phosphates; Stereoisomerism; Thionucleotides | 2006 |
1 other study(ies) available for phosphorodithioic acid and Benign Neoplasms
| Article | Year |
|---|---|
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
Topics: Administration, Intravenous; Animals; Binding Sites; Cell Line, Tumor; Half-Life; Humans; Immunotherapy; Membrane Proteins; Mice; Molecular Docking Simulation; Neoplasms; Nucleotides, Cyclic; Phosphates; Pyrimidines; Rats; Structure-Activity Relationship; Transplantation, Heterologous | 2021 |